{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:41:29Z","timestamp":1777880489846,"version":"3.51.4"},"reference-count":11,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["SAGE Open Medicine"],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Community pharmacy has become a major access point for several types of vaccinations. Despite the success of vaccination programs like influenza, pneumococcal, and herpes zoster, the rates of human papillomavirus vaccination continue to lag.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The primary objective is to describe and report on the impact of a multimodal series of pharmacist-led educational interventions on human papillomavirus vaccination rates in a community pharmacy setting. The primary outcome of this study was change in pharmacist-delivered human papillomavirus vaccination throughout a corresponding 8-week period in 2014 and 2015.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A single-center, quasi-experimental interrupted time series mixed-methods pilot study was used to investigate a pharmacist-led, multimodal educational intervention approach to improve human papillomavirus vaccination rates in the community.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>During the 2014 control period, there were no human papillomavirus vaccines dispensed or administered according to the internal prescription dispensing software. In 2015, a total of 10 patients indicated that they were vaccinated, with 9 patients receiving their first dose and 1 patient receiving his or her second dose at the pharmacy. Pharmacist recommendation was the most reported education method for increasing patient awareness of the human papillomavirus vaccine (n\u2009=\u200910).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study demonstrates pharmacist designed, educational interventions may impact human papillomavirus vaccination rates in the community. Further community-based research with larger sample sizes is warranted to verify these results. Due to the unique barriers to human papillomavirus vaccination, a multimodal and inter-professional approach such as the one presented here is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/2050312116682128","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T08:43:59Z","timestamp":1489567439000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":13,"title":["A multimodal approach to improving human papillomavirus vaccination in a community pharmacy setting"],"prefix":"10.1177","volume":"4","author":[{"given":"Kenneth C","family":"Hohmeier","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, The University of Tennessee Health Science Center, Nashville, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna D","family":"Randolph","sequence":"additional","affiliation":[{"name":"EntrustRx, Spring Hill, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy Taliaferro","family":"Smith","sequence":"additional","affiliation":[{"name":"Reeves-Sain Drug Store, Murfreesboro, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy M","family":"Hagemann","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, The University of Tennessee Health Science Center, Nashville, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,12,14]]},"reference":[{"issue":"05","key":"bibr1-2050312116682128","first-page":"1","volume":"63","author":"Markowitz LE","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"bibr2-2050312116682128","doi-asserted-by":"publisher","DOI":"10.1007\/s10900-015-9995-2"},{"key":"bibr3-2050312116682128","first-page":"591","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMMR Morb Mort Wkly Rep"},{"key":"bibr4-2050312116682128","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2014.14532"},{"key":"bibr5-2050312116682128","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.12.020"},{"key":"bibr6-2050312116682128","unstructured":"US Department of Health and Human Services. Accelerating HPV vaccine uptake: urgency for action to prevent cancer. A report to the president of the United States from the president\u2019s cancer panel. Bethesda, MD: National Cancer Institute, 2014, http:\/\/deainfo.nci.nih.gov\/advisory\/pcp\/annualReports\/HPV\/index.htm (accessed 12 September 2014)."},{"key":"bibr7-2050312116682128","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2008.07032"},{"key":"bibr8-2050312116682128","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.08.040"},{"key":"bibr9-2050312116682128","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150984"},{"key":"bibr10-2050312116682128","first-page":"CD005188","volume":"7","author":"Thomas RE","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr11-2050312116682128","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2013.871204"}],"container-title":["SAGE Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050312116682128","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2050312116682128","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050312116682128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:13:06Z","timestamp":1777594386000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2050312116682128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":11,"alternative-id":["10.1177\/2050312116682128"],"URL":"https:\/\/doi.org\/10.1177\/2050312116682128","relation":{},"ISSN":["2050-3121","2050-3121"],"issn-type":[{"value":"2050-3121","type":"print"},{"value":"2050-3121","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,1]]},"article-number":"2050312116682128"}}